Decoy Therapeutics is trading 7.44% up at $3.28 after opening higher on September 1, 2026, with no clear reason for the move.
- No clear company-specific announcement, filing, earnings release, or major event explains the gain.
- Recent publicly indexed items concern earlier pipeline developments and corporate information, rather than a new September 1 catalyst.
- The broader biotech sector is down, so the gain does not track the sector and its immediate reason remains unclear.